NEW YORK – Ortho Clinical Diagnostics announced on Tuesday that the US Food and Drug Administration has issued Emergency Use Authorization for the company's Vitros SARS-CoV-2 Antigen test for detection of the coronavirus.
According to the Raritan, New Jersey-based firm, the test is the first high-volume COVID-19 antigen test to receive EUA. It previously was CE marked in November.